ArticleFrontiers in neurology2025
Navigating the diagnostic challenges of myoclonus in neurodegenerative disorders: video-EEG/polygraphy, clinical vignettes, and narrative analysis.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Celiac Disease and the Nervous System: A Comprehensive Overview of Neurological Manifestations and Underlying Mechanisms.Neuromolecular medicine · 2026Review
- Myoclonus in geriatric dogs and its association with canine cognitive dysfunction: an online survey.Frontiers in veterinary science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Myoclonus-sudden, brief, involuntary muscle jerks-is a frequent and diagnostically challenging feature across neurodegenerative disorders. Unlike epileptic myoclonus, these manifestations rarely involve seizures; they often reflect extensive multisystemic pathology (cortical, subcortical, peripheral). Distinguishing neurodegenerative myoclonus from other movement disorders and pinpointing its origin is crucial for accurate diagnosis, prognosis, and tailored management. This narrative analysis explores the diverse phenomenology of myoclonus in neurodegenerative conditions, emphasizing how presentations often differ from typical epileptic myoclonus, which necessitates a nuanced diagnostic approach. We also highlight the indispensable role of video-electroencephalography (video-EEG) with polygraphy in this context. Methods: We synthesized existing literature on myoclonus in neurodegenerative disorders, complemented by illustrative clinical vignettes. The diagnostic utility of video-EEG with polygraphy was critically examined, focusing on its capacity to integrate motor behavior analysis with concurrent EEG and electromyographic (EMG) activity. Results: Myoclonus in neurodegenerative conditions (e.g., dementias, basal ganglia degenerations, spinocerebellar degenerations) presents with diverse phenomenology, often differing significantly from typical epileptic myoclonus. Video-EEG/polygraphy emerged as the gold standard, enabling precise characterization (focal, multifocal, generalized, rhythmicity, triggers) and localization of origin. Its adaptable protocols are fundamental for capturing the fluctuating, context-dependent nature of myoclonus in these progressive conditions, and for distinguishing pathological cortical excitability from subcortical or spinal origins. Conclusion: Video-EEG/polygraphy provides objective, real-time insights into the complex interplay of brain and muscle activity, profoundly refining our understanding of neurodegenerative myoclonus. This guides accurate differential diagnosis and informs effective patient care, proving essential for optimal patient management and prognosis in these challenging conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.